Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study.

Imiela T, Budaj A.

Clin Drug Investig. 2017 Dec;37(12):1175-1181. doi: 10.1007/s40261-017-0577-1.

2.

Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study.

Obokata M, Kane GC, Reddy YN, Olson TP, Melenovsky V, Borlaug BA.

Circulation. 2017 Feb 28;135(9):825-838. doi: 10.1161/CIRCULATIONAHA.116.024822. Epub 2016 Dec 30.

3.
4.

Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study.

Taylor CJ, Roalfe AK, Iles R, Hobbs FR; REFER investigators, Barton P, Deeks J, McCahon D, Cowie MR, Sutton G, Davis RC, Mant J, McDonagh T, Tait L.

Br J Gen Pract. 2017 Feb;67(655):e94-e102. doi: 10.3399/bjgp16X688393. Epub 2016 Dec 5.

5.

Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure.

Butler J, Hernandez AF, Anstrom KJ, Kalogeropoulos A, Redfield MM, Konstam MA, Tang WH, Felker GM, Shah MR, Braunwald E.

JACC Heart Fail. 2016 Sep;4(9):726-35. doi: 10.1016/j.jchf.2016.06.003. Epub 2016 Aug 10.

6.

Evaluation of a provocative dyspnea severity score in acute heart failure.

AbouEzzeddine OF, Lala A, Khazanie PP, Shah R, Ho JE, Chen HH, Pang PS, McNulty SE, Anstrom KJ, Hernandez AF, Redfield MM; NHLBI Heart Failure Clinical Research Network.

Am Heart J. 2016 Feb;172:34-41. doi: 10.1016/j.ahj.2015.10.009. Epub 2015 Oct 20.

7.

Diagnostic values of NT-proBNP in acute dyspnea among elderly patients.

Su Q, Liu H, Zhang X, Dang W, Liu R, Zhao X, Yuan X, Qin Y, Zhang J, Chen C, Xia Y.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13471-6. eCollection 2015.

8.

Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I.

Hoffmann U, Espeter F, Weiß C, Ahmad-Nejad P, Lang S, Brueckmann M, Akin I, Neumaier M, Borggrefe M, Behnes M.

BMC Cardiovasc Disord. 2015 Jun 14;15:50. doi: 10.1186/s12872-015-0026-0.

10.

Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension.

Bielecka-Dabrowa A, Michalska-Kasiczak M, Gluba A, Ahmed A, Gerdts E, von Haehling S, Rysz J, Banach M.

Sci Rep. 2015 Mar 9;5:8916. doi: 10.1038/srep08916.

11.

Noninvasive tests for the diagnostic evaluation of dyspnea among outpatients: the Multi-Ethnic Study of Atherosclerosis lung study.

Oelsner EC, Lima JA, Kawut SM, Burkart KM, Enright PL, Ahmed FS, Barr RG.

Am J Med. 2015 Feb;128(2):171-180.e5. doi: 10.1016/j.amjmed.2014.09.023. Epub 2014 Oct 15.

12.

Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.

Fox PR, Oyama MA, Hezzell MJ, Rush JE, Nguyenba TP, DeFrancesco TC, Lehmkuhl LB, Kellihan HB, Bulmer B, Gordon SG, Cunningham SM, MacGregor J, Stepien RL, Lefbom B, Adin D, Lamb K.

J Vet Intern Med. 2015 Jan;29(1):171-9. doi: 10.1111/jvim.12472. Epub 2014 Oct 10.

13.

Utility of NT-proBNP as a rule-out test for left ventricular dysfunction in very old people with limiting dyspnoea: the Newcastle 85+ Study.

Collerton J, Kingston A, Yousaf F, Davies K, Kenny A, Neely D, Martin-Ruiz C, MacGowan G, Robinson L, Kirkwood TB, Keavney B.

BMC Cardiovasc Disord. 2014 Sep 26;14:128. doi: 10.1186/1471-2261-14-128.

14.

Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

Madamanchi C, Alhosaini H, Sumida A, Runge MS.

Int J Cardiol. 2014 Oct 20;176(3):611-7. doi: 10.1016/j.ijcard.2014.08.007. Epub 2014 Aug 9. Review.

15.

The five-point Likert scale for dyspnea can properly assess the degree of pulmonary congestion and predict adverse events in heart failure outpatients.

Weber CK, Miglioranza MH, Moraes MA, Sant'anna RT, Rover MM, Kalil RA, Leiria TL.

Clinics (Sao Paulo). 2014;69(5):341-6.

16.

Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trial.

van Riet EE, Hoes AW, Limburg A, van der Hoeven H, Landman MA, Rutten FH.

BMC Cardiovasc Disord. 2014 Jan 8;14:1. doi: 10.1186/1471-2261-14-1.

17.

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP).

Maries L, Manitiu I.

Cardiovasc J Afr. 2013 Aug;24(7):286-9. doi: 10.5830/CVJA-2013-055. Review.

18.

The role of natriuretic peptides for the diagnosis of left ventricular dysfunction.

Palazzuoli A, Beltrami M, Ruocco G, Pellegrini M, Nuti R.

ScientificWorldJournal. 2013 Sep 28;2013:784670. doi: 10.1155/2013/784670. eCollection 2013. Review.

19.

Cardiopulmonary involvement in Puumala hantavirus infection.

Rasmuson J, Lindqvist P, Sörensen K, Hedström M, Blomberg A, Ahlm C.

BMC Infect Dis. 2013 Oct 28;13:501. doi: 10.1186/1471-2334-13-501.

20.

Role of the NT-proBNP level in the diagnosis of pediatric heart failure and investigation of novel combined diagnostic criteria.

Lin CW, Zeng XL, Jiang SH, Wu T, Wang JP, Zhang JF, Ou YH.

Exp Ther Med. 2013 Oct;6(4):995-999. Epub 2013 Aug 5.

Supplemental Content

Loading ...
Support Center